Influence of body mass index on survival in indolent and mantle cell lymphomas: analysis of the StiL NHL1 trial - Wikidata - wikimedia - TriplyDB

Influence of body mass index on survival in indolent and mantle cell lymphomas: analysis of the StiL NHL1 trial

Influence of body mass index on survival in indolent and mantle cell lymphomas: analysis of the StiL NHL1 trial

http://www.wikidata.org/entity/Q33841425

about

Influence of body mass index on survival in indolent and mantle cell lymphomas: analysis of the StiL NHL1 trial

http://www.wikidata.org/entity/Q33841425

description

2017 nî lūn-bûn

@nan

2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Influence of body mass index o ...... nalysis of the StiL NHL1 trial

@ast

Influence of body mass index o ...... nalysis of the StiL NHL1 trial

@en

type

label

Influence of body mass index o ...... nalysis of the StiL NHL1 trial

@ast

Influence of body mass index o ...... nalysis of the StiL NHL1 trial

@en

prefLabel

Influence of body mass index o ...... nalysis of the StiL NHL1 trial

@ast

Influence of body mass index o ...... nalysis of the StiL NHL1 trial

@en

P1433

Q33841425-E62A93BB-58A0-4F90-9801-FFEF12EB2A6C

P1476

Q33841425-640286AE-01EC-44FD-B235-F3412B2E665C

P2093

Q33841425-003C8525-C5D5-4F79-8C16-D3D141A3A41D

Q33841425-02E193C2-5710-4B99-9E1E-1F938864E116

Q33841425-4B654947-0A3C-4365-8155-3C6D05579085

Q33841425-9A2003C0-9C43-4C37-960B-88E9F603B9E8

P2860

Q33841425-0E268704-E780-4BDD-835F-14C2D4E8B458

Q33841425-0ECF98A9-F09E-429E-BEFE-85288E061CFE

Q33841425-0FC83781-41E5-4675-B06B-F7075CFAE96E

Q33841425-1783F56A-3201-4894-9E34-B7D47951F795

Q33841425-39861480-0F77-45FE-9C44-795DBA553E8C

Q33841425-46269E20-486C-4120-B941-289DC8A28D93

Q33841425-4D99EBDC-A6D1-4187-A95C-31C771FE2DFB

Q33841425-5C25C1F8-5FCD-4467-A893-97DFE0E140B5

Q33841425-7A1C0E8F-F449-4E35-A63A-14E4DA12B2E2

Q33841425-7D07F690-43AF-4061-814D-87608BB285DB

P304

Q33841425-43FA7D0D-83E1-4C46-B1B2-97BF96FF1A23

P31

Q33841425-16C4759D-97DC-46F5-9460-4881349DB8D3

P356

Q33841425-FAB9D52A-E11B-4B69-880B-6EA620C53D37

P433

Q33841425-D465E2B1-9C38-4993-A151-E1B89151CF44

P478

Q33841425-65562818-3D73-4F7E-AE51-FC8D0C9D0DD2

P50

Q33841425-3D527F45-9568-4FE4-A499-1F2C5E8576AF

Q33841425-46F5BC67-C92E-481B-A9B2-23135B68C807

Q33841425-A4BBB164-2016-4B24-8E17-DE7FDCFA280C

Q33841425-FB4BE162-656D-440F-BEBA-D07822CAAF6E

P577

Q33841425-10C771F3-5596-4373-9802-B88B1FC7D978

P698

Q33841425-CEC8315D-FDD3-4968-923A-7E5444DF89D6

P932

Q33841425-4D9DA935-36A2-4662-A3BB-8B0F2FF1B7BB

P356

S00277-017-3003-0

P1433

Annals of Hematology

P1476

Influence of body mass index o ...... nalysis of the StiL NHL1 trial

@en

P2093

Juergen Barth

http://www.w3.org/2001/XMLSchema#string

Mathias Rummel

http://www.w3.org/2001/XMLSchema#string

Richard Greil

http://www.w3.org/2001/XMLSchema#string

Thomas Melchardt

http://www.w3.org/2001/XMLSchema#string

P2860

Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee

Adipocytokines: mediators linking adipose tissue, inflammation and immunity

National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants

Insulin-like growth factor 1 receptor is a prognostic factor in classical Hodgkin lymphoma.

Chronic inflammation in obesity and the metabolic syndrome.

Effects of obesity on pharmacokinetics implications for drug therapy.

Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.

P304

1155-1162

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00277-017-3003-0

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P50

Georg Hopfinger

P577

2017-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28456850

http://www.w3.org/2001/XMLSchema#string

P932

5486799

http://www.w3.org/2001/XMLSchema#string